TARS
Tarsus Pharmaceuticals Inc
$67.96
-0.31% ($0.21)
Volume
296,389
52W High
$85.25
52W Low
$38.51
Market Cap
$2.83B
What to Watch This Quarter
Based on historical dataConsensus EPS
-$0.08
Whisper EPS
-$0.09
1.8% below consensus
Last Quarter
--
Current Streak
2 Beats
Avg Surprise (4Q)
+1.89%
Next Earnings Report
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q4 2025
Feb 23, 2026
1-Day:
+7.79%
Q3 2025
Nov 5, 2025
1-Day:
-0.16%
5-Day:
+6.73%
Q3 2025
Nov 4, 2025
1-Day:
-4.62%
Q2 2025
Aug 6, 2025
1-Day:
+15.15%
5-Day:
+20.24%
Revenue & Financial Performance
Revenue Whisper
$233.0M
TWN Proprietary Estimate
Last Quarter Revenue
$151.7M
+128.4% YoY
Gross Margin
92.8%
Net Margin: -5.5%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $151.7M | +128.4% | 92.8% | -5.3% | -$8.4M |
| Q3'25 | $118.7M | +146.7% | 79.3% | -12.2% | -$12.6M |
| Q2'25 | $102.7M | +151.5% | 93.9% | -21.6% | -$20.3M |
| Q1'25 | $78.3M | +183.7% | 93.4% | -33.6% | -$25.1M |
| Q4'24 | $66.4M | +407.9% | 92.6% | -36.8% | -$23.1M |
| Q3'24 | $48.1M | +2,471.8% | 93.3% | -52.3% | -$23.4M |
| Q2'24 | $40.8M | +167.2% | 92.6% | -81.6% | -$33.3M |
| Q1'24 | $27.6M | +1,004.6% | 94.0% | -136.5% | -$35.7M |
Company Information
Symbol
TARS
Company
Tarsus Pharmaceuticals Inc
Market Cap
$2.83B
Next Earnings
Mar 16, 2026